Literature DB >> 24777226

Pediatric anthrax clinical management.

John S Bradley, Georgina Peacock, Steven E Krug, William A Bower, Amanda C Cohn, Dana Meaney-Delman, Andrew T Pavia.   

Abstract

Anthrax is a zoonotic disease caused by Bacillus anthracis, which has multiple routes of infection in humans, manifesting in different initial presentations of disease. Because B anthracis has the potential to be used as a biological weapon and can rapidly progress to systemic anthrax with high mortality in those who are exposed and untreated, clinical guidance that can be quickly implemented must be in place before any intentional release of the agent. This document provides clinical guidance for the prophylaxis and treatment of neonates, infants, children, adolescents, and young adults up to the age of 21 (referred to as "children") in the event of a deliberate B anthracis release and offers guidance in areas where the unique characteristics of children dictate a different clinical recommendation from adults.
Copyright © 2014 by the American Academy of Pediatrics.

Entities:  

Keywords:  anthrax; anthrax vaccine; biological weapon; bioterrorism; children; pediatrics; prophylaxis

Mesh:

Substances:

Year:  2014        PMID: 24777226      PMCID: PMC4479255          DOI: 10.1542/peds.2014-0563

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  101 in total

1.  Neurotoxicity of carbapenem antibiotics: consequences for their use in bacterial meningitis.

Authors:  S R Norrby
Journal:  J Antimicrob Chemother       Date:  2000-01       Impact factor: 5.790

2.  Human inhalation anthrax. A report of three fatal cases.

Authors:  W S ALBRINK; S M BROOKS; R E BIRON; M KOPEL
Journal:  Am J Pathol       Date:  1960-04       Impact factor: 4.307

3.  Case records of the Massachusetts General Hospital. Case 25-2010. A 24-year-old woman with abdominal pain and shock.

Authors:  Mark S Klempner; Elizabeth A Talbot; Susanna I Lee; Sherif Zaki; Mary Jane Ferraro
Journal:  N Engl J Med       Date:  2010-08-19       Impact factor: 91.245

4.  Subcutaneous anthrax in three intravenous drug users: a new clinical diagnosis.

Authors:  D Knox; G Murray; M Millar; D Hamilton; M Connor; R D Ferdinand; G A Jones
Journal:  J Bone Joint Surg Br       Date:  2011-03

5.  Pharmacokinetic and clinical evaluation of serious infections in premature and newborn infants under therapy with imipenem/cilastatin.

Authors:  M Böswald; C Döbig; C Kändler; C Krüger; J Scharf; F Soergel; S Zink; J P Guggenbichler
Journal:  Infection       Date:  1999       Impact factor: 3.553

Review 6.  Management of anthrax meningitis.

Authors:  James J Sejvar; Fred C Tenover; David S Stephens
Journal:  Lancet Infect Dis       Date:  2005-05       Impact factor: 25.071

7.  Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection.

Authors:  J Zimbelman; A Palmer; J Todd
Journal:  Pediatr Infect Dis J       Date:  1999-12       Impact factor: 2.129

8.  The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteria.

Authors:  Timothy D Read; Scott N Peterson; Nicolas Tourasse; Les W Baillie; Ian T Paulsen; Karen E Nelson; Hervé Tettelin; Derrick E Fouts; Jonathan A Eisen; Steven R Gill; Erik K Holtzapple; Ole Andreas Okstad; Erlendur Helgason; Jennifer Rilstone; Martin Wu; James F Kolonay; Maureen J Beanan; Robert J Dodson; Lauren M Brinkac; Michelle Gwinn; Robert T DeBoy; Ramana Madpu; Sean C Daugherty; A Scott Durkin; Daniel H Haft; William C Nelson; Jeremy D Peterson; Mihai Pop; Hoda M Khouri; Diana Radune; Jonathan L Benton; Yasmin Mahamoud; Lingxia Jiang; Ioana R Hance; Janice F Weidman; Kristi J Berry; Roger D Plaut; Alex M Wolf; Kisha L Watkins; William C Nierman; Alyson Hazen; Robin Cline; Caroline Redmond; Joanne E Thwaite; Owen White; Steven L Salzberg; Brendan Thomason; Arthur M Friedlander; Theresa M Koehler; Philip C Hanna; Anne-Brit Kolstø; Claire M Fraser
Journal:  Nature       Date:  2003-05-01       Impact factor: 49.962

Review 9.  The roles of anthrax toxin in pathogenesis.

Authors:  Mahtab Moayeri; Stephen H Leppla
Journal:  Curr Opin Microbiol       Date:  2004-02       Impact factor: 7.934

10.  Conference report on public health and clinical guidelines for anthrax.

Authors:  Eric Jacob Stern; Kristin Broome Uhde; Sean Vincent Shadomy; Nancy Messonnier
Journal:  Emerg Infect Dis       Date:  2008-04       Impact factor: 6.883

View more
  5 in total

1.  Planning Considerations for State, Local, Tribal, and Territorial Partners to Receive Medical Countermeasures From CDC's Strategic National Stockpile During a Public Health Emergency.

Authors:  Tina R Bhavsar; Deborah L Esbitt; Patricia A Yu; Yon Yu; Susan E Gorman
Journal:  Am J Public Health       Date:  2018-09       Impact factor: 9.308

2.  PRIORITIZATION OF PEDIATRIC CBRNE DISASTER PREPAREDNESS EDUCATION AND TRAINING NEEDS.

Authors:  David Siegel; Kandra Strauss-Riggs; Scott Needle
Journal:  Clin Pediatr Emerg Med       Date:  2014-12-01

3.  Building Children's Preparedness Capacity at the Centers for Disease Control and Prevention One Event at a Time, 2009-2018.

Authors:  Rebecca T Leeb; Jessica L Franks; Eric J Dziuban; Wendy Ruben; Michael Bartenfeld; Cynthia F Hinton; Kevin Chatham-Stephens; Georgina Peacock
Journal:  Am J Public Health       Date:  2019-09       Impact factor: 9.308

Review 4.  Antimicrobial Treatment for Systemic Anthrax: Analysis of Cases from 1945 to 2014 Identified Through a Systematic Literature Review.

Authors:  Satish K Pillai; Eileen Huang; Julie T Guarnizo; Jamechia D Hoyle; Stefan Katharios-Lanwermeyer; Theresa K Turski; William A Bower; Katherine A Hendricks; Dana Meaney-Delman
Journal:  Health Secur       Date:  2015-12-01

5.  Chronic Ulcers and Malnutrition in an African Patient.

Authors:  Timothy G Singer; Monica A Bray; Audrey Chan; Saki Ikeda; Brittany Walters; Maren Y Fuller; Carla Falco
Journal:  Pediatrics       Date:  2020-11       Impact factor: 7.124

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.